AndersHJ. 1998. Compression syndromes caused by substernal goiters. Postgrad Med J, 74:327–329.
2.
ForoulisCN, RammosKS, SileliMN, PapakonstantinouC. 2009. Primary intrathoracic goiter: a rare and potentially serious entity. Thyroid, 19:213–218.
3.
CichonS, BarczynskiM, RogulaT. 1998. Intrathoracic goiter as a cause of superior vena cava syndrome. Przegl Lek, 55:626–628.
4.
AastedA, BertelsenS. 1981. Superior vena caval syndrome in benign mediastinal goiter. Acta Chir Scand, 147:405–408.
5.
HinojosaMC, FernandezMI, ErguetaMP, GonzalezSE. 1998. Etiologic prevalence of superior vena cava syndrome. Am Med Interna, 15:531–533.
6.
RossDS. 2009. Radiodine therapy for nontoxic multinodular goiter and goitrous Hashimoto's. www.uptodate.com/online/content/topic.do?topicKey=thyroid/15693&selectedTitle=1%7E150&source=search_result3 February 2009 edition.
7.
HuysmansDA, HermusAR, CorstensFH, BarentszJO, KloppenborgPW. 1994. Large, compressive goiters treated with radioiodine. Ann Intern Med, 121:757–762.
8.
SilvaMN, RubioIG, RomaoR, GebrinEM, BuchpiguelC, TomimoriE, CamargoR, CardiaMS, Medeiros-NetoG. 2004. Administration of a single dose of recombinant human thyrotrophin enhances the efficacy of radioiodine treatment of large compressive multinodular goitres. Clin Endocrinol (Oxf ), 60:300–308.
9.
BonnemaSJ, NielsenVE, Boel-JorgensenH, GrupeP, AndersenPB, BastholtL, HegedusL. 2008. Recombinant human thyrotropin-stimulated radioiodine therapy of large nodular goiters facilitates tracheal decompression and improves inspiration. J Clin Endocrinol Metab, 93:3981–3984.
10.
RossDS. 2009. Treatment of obstructive or substernal goiter. www.uptodate.com/online/content/topic.do?topicKey=thyroid/11056&selectedTitle=1%7E150&source=search_result3 February 2009 edition.